Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?

Taking stock of the drug industry, from the lab to the medicine chest

June 17, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly? "In one fell swoop, it can make a difference, and would address patent thickets," explained Sean Tu, a law professor at West Virginia University. By Ed Silverman STAT+ | Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data The tests for ctDNA are seen as good indicator of whether cancer will return after surgery. But they don't always clarify the next step. By Angus Chen Ambitious federal study failed to curb opioid deaths, NIH announces Despite $344 million awarded to communities, there was no significant difference in fatal overdoses. But the pandemic may have been a factor. By Lev Facher

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser